# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY

I Background Information:

# B Applicant

Hangzhou Alltest Biotech Co.,Ltd

# C Proprietary and Established Names

AllTest Multi-Drug Rapid Test Cup; AllTest Multi-Drug Test Cup

# D Regulatory Information

<table><tr><td colspan="1" rowspan="1">ProductCode(s)</td><td colspan="1" rowspan="1">Classification</td><td colspan="1" rowspan="1">RegulationSection</td><td colspan="1" rowspan="1">Panel</td></tr><tr><td colspan="1" rowspan="1">NFT</td><td colspan="1" rowspan="1">Class I</td><td colspan="1" rowspan="1">21 CFR 862.3100 -Amphetamine testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">PTH</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3150 -Barbiturate testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NGL</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3650 -Opiate test system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NFV</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3170 -Benzodiazepine testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NFY</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3250 -Cocaine and cocainemetabolite test system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">PTG</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3620 -Methadone testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NGG</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3610 -Methamphetaminetest system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">QBF</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3700 -Propoxyphene testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NGM</td><td colspan="1" rowspan="1">Unclassified</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">QAW</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3910 -Tricyclicantidepressant drugstest system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NFW</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3870 -Cannabinoid testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NGI</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3640 -Morphine test system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr></table>

# II Submission/Device Overview:

A Purpose for Submission:

New Device (adding four additional analytes to the previously cleared device under K233019)

# B Measurand:

Amphetamine, Secobarbital, Benzodiazepines, Buprenorphine, Cocaine, Marijuana, Methadone, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Phencyclidine, Nortriptyline, Oxycodone, 2-ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine, Tramadol, Propoxyphene, Fentanyl and 6-monoacetylmorphine.

# C Type of Test:

Qualitative lateral flow immunoassay

III Intended Use/Indications for Use:

A Intended Use(s):

See Indications for Use below.

# B Indication(s) for Use:

AllTest Multi-Drug Rapid Test Cup tests are competitive binding, lateral flow immunochromatographic assays for qualitative and simultaneous detection of Amphetamine, Buprenorphine, Secobarbital, Benzodiazepines, Cocaine, 2- ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, Nortriptyline, Marijuana, Tramadol, Propoxyphene, Fentanyl and 6-monoacetylmorphine in human urine at the cutoff concentrations of:

Drug (Identifier)

Cut-off level

Amphetamine (AMP)   
Buprenorphine (BUP)   
Secobarbital (BAR)   
Benzodiazepines (BZO)   
Cocaine (COC)   
2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)   
Methamphetamine (MET)   
Methylenedioxymethamphetamine (MDMA)   
Morphine (MOP/OPI)   
Methadone (MTD)   
Oxycodone (OXY)   
Phencyclidine (PCP)   
Nortriptyline (TCA)   
Marijuana (THC)   
Tramadol (TRA)   
Propoxyphene (PPX)   
Fentanyl(FYL)   
6-monoacetylmorphine (6-MAM)   
500 or $1 0 0 0 ~ \mathrm { { n g / m L } }$   
10 ng/mL   
300 ng/mL   
300 ng/mL   
150 or 300 ng/mL   
300 ng/mL   
500 or 1000 ng/mL   
500 ng/mL   
300 or 2000 ng/mL   
300 ng/mL   
100 ng/mL   
25 ng/mL 1000 ng/mL 50 ng/mL 100 ng/mL 300 ng/mL 1 ng/mL 10 ng/mL

AllTest Multi-Drug Rapid Test Cup can be a single drug test cup or used for any combination of the above listed analytes. It is for in vitro diagnostic use only. It is intended for OTC use.

The tests may yield positive results for the prescription drugs when taken at or above prescribed doses. It is not intended to distinguish between prescription use or abuse of these drugs. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly in evaluating a preliminary positive result.

The tests provide only preliminary results. To obtain a confirmed analytical result, a more specific alternate chemical method must be used. GC/MS or LC/MS is the recommended confirmatory method.

AllTest Multi-Drug Test Cup tests are competitive binding, lateral flow immunochromatographic assays for qualitative and simultaneous detection of Amphetamine, Buprenorphine, Secobarbital, Benzodiazepines, Cocaine, 2- ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, Nortriptyline, Marijuana, Tramadol, Propoxyphene Fentanyl and 6- monoacetylmorphine in human urine at the cutoff concentration of:

Drug (Identifier)   
Amphetamine (AMP)   
Buprenorphine (BUP)   
Secobarbital (BAR)   
Benzodiazepines (BZO)   
Cocaine (COC)   
2-ethylidene-1,5-dimethyl-3,3-   
diphenylpyrrolidine (EDDP)   
Methamphetamine (MET)   
Methylenedioxymethamphetamine (MDMA)

Calibrator Cut-off (ng/mL)   
d-Amphetamine 500 or 1000   
Buprenorphine 10   
Secobarbital 300   
Oxazepam 300   
Benzoylecgonine 150 or 300   
2-ethylidene-1,5-dimethyl- 300   
3,3-diphenylpyrrolidine   
d-Methamphetamine 500 or 1000   
d,l-Methylenedioxymethamphetamine 500

Morphine (MOP/OPI)   
Methadone (MTD)   
Oxycodone (OXY)   
Phencyclidine (PCP)   
Nortriptyline (TCA)   
Marijuana (THC)   
Tramadol (TRA)   
Propoxyphene (PPX)   
Fentanyl (FYL)   
6-monoacetylmorphine (6-MAM)

Morphine 300 or 2000   
Methadone 300   
Oxycodone 100   
Phencyclidine 25   
Nortriptyline 1000   
11-nor- $\Delta 9$ -THC-9 COOH 50   
Tramadol 100   
Propoxyphene 300   
Fentanyl 1   
6-monoacetylmorphine 10

AllTest Multi-Drug Test Cup can be a single drug test cup or used for any combination of the above listed analytes. It is for in vitro diagnostic use only.

The tests may yield positive results for the prescription drugs when taken at or above prescribed doses. It is not intended to distinguish between prescription use or abuse of these drugs. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly in evaluating a preliminary positive result.

The tests provide only preliminary results. To obtain a confirmed analytical result, a more specific alternate chemical method must be used. GC/MS or LC/MS is the recommended confirmatory method.

C Special Conditions for Use Statement(s): OTC - Over The Counter   
D Special Instrument Requirements: Not Applicable. (These devices are single use and disposable.)

# IV Device/System Characteristics:

# A Device Description:

AllTest Multi-Drug Test Cup tests are competitive binding, lateral flow immunochromatographic assays for qualitative and simultaneous detection of Amphetamine, Buprenorphine, Secobarbital, Benzodiazepines, Cocaine, 2- ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, Nortriptyline, Marijuana, Tramadol, Propoxyphene, Fentanyl and 6- monoacetylmorphine in human urine. The tests provide only preliminary results. To obtain a confirmed analytical result, a more specific alternate chemical method must be used. GC/MS or LC/MS is the recommended confirmatory method.

# B Principle of Operation:

The Multi-Drug Rapid Test Cup is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes monoclonal antibodies to selectively detect elevated levels of specific drugs in urine. During testing, a urine specimen migrates upward by capillary action. A drug, if present in the urine specimen below its cut-off concentration, will not saturate the binding sites of its specific antibody. The antibody will then react with the drug-protein conjugate and a visible colored line will show up in the test region of the specific drug dipstick.

The presence of drug above the cut-off concentration will saturate all the binding sites of the antibody. Therefore, the colored line will not form in the test region.

A drug-positive urine specimen will not generate a colored line in the specific test region of the dipstick because of drug competition, while a drug-negative urine specimen will generate a line in the test region because of the absence of drug competition.

To serve as a procedural control, a colored line will always appear at the control region, indicating that proper volume of specimen has been added and membrane wicking has occurred.

# V Substantial Equivalence Information:

A Predicate Device Name(s):

AllTest Multi-Drug Rapid Test Cup; AllTest Multi-Drug Rapid Test Panel; AllTest Multi-DrugRapid Test Cup Rx; AllTest Multi-Drug Rapid Test Panel Rx

# B Predicate 510(k) Number(s):

K233019

C Comparison with Predicate(s):

<table><tr><td colspan="1" rowspan="1">Device &amp; PredicateDevice(s):</td><td colspan="1" rowspan="1">CandidateK244043</td><td colspan="1" rowspan="1">PredicateK233019</td></tr><tr><td colspan="1" rowspan="1">Device Trade Name</td><td colspan="1" rowspan="1">AllTest Multi-DrugRapid Test CupAllTest Multi-DrugTest Cup</td><td colspan="1" rowspan="1">AllTest Multi-DrugRapid Test CupAllTest Multi-DrugRapid Test Cup RxAllTest Multi-DrugRapid Test PanelAllTest Multi-DrugRapid Test Panel Rx</td></tr><tr><td colspan="1" rowspan="1">General DeviceCharacteristic Similarities</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Intended Use/IndicationsFor Use</td><td colspan="1" rowspan="1">For the qualitativedetermination of drugsand drug metabolites inhuman urine.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Human Urine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Methodology</td><td colspan="1" rowspan="1">Competitive binding,lateral flowimmunochromatographi</td><td colspan="1" rowspan="1">Same</td></tr><tr><td></td><td>c assays based on the principle of antigen antibody immunochemistry.</td><td></td></tr><tr><td>General Device Characteristic Differences</td><td>Amphetamine (AMP):</td><td></td></tr><tr><td>Calibrator and Cutoff Values</td><td>500 or 1000 ng/ml Benzodiazepines (BZO): 300 ng/mL Cocaine (COC): 150 or 300 ng/mL 11-Nor-Δ9- Tetrahydrocannabinol- 9-COOH (THC): 50 ng/mL Methamphetamine (MET): 500 or 1000 ng/mL Morphine (MOP/OPI): 300 or 2000 ng/mL Oxycodone (OXY): 100 ng/mL Secobarbital (BAR): 300 ng/mL Methadone (MTD): 300 ng/mL Buprenorphine (BUP): 10 ng/mL D,L- Methylenedioxymetham phetamine (MDMA): 500 ng/mL Phencyclidine (PCP): 25 ng/mL Nortriptyline (TCA): 1000 ng/mL 2-ethylidene-1,5- dimethyl-3,3- diphenylpyrrolidine (EDDP): 300 ng/mL Tramadol (TRA): 100 ng/mL Propoxyphene (PPX): 300 ng/mL Fentanyl (FYL):1 ng/mL</td><td>Same except TRA 100 ng/mL PPX 300 ng/mL FYL 1 ng/mL 6-MAM 10 ng/mL</td></tr><tr><td></td><td>6- Monoacetylmorphine(6- MAM): 10 ng/mL</td><td></td></tr></table>

# VI Standards/Guidance Documents Referenced:

None.

VII Performance Characteristics (if/when applicable):

# A Analytical Performance:

# 1. Precision/Reproducibility:

Precision studies were carried out for samples with concentrations of $- 1 0 0 \%$ cutoff, $- 7 5 \%$ cutoff, $- 5 0 \%$ cutoff, $- 2 5 \%$ cutoff, cutoff, $+ 2 5 \%$ cutoff, $+ 5 0 \%$ cutoff, $+ 7 5 \%$ cutoff and $+ 1 0 0 \%$ cutoff using 3 lots of the AllTest Multi-Drug Rapid Test Cup. These samples were prepared by spiking drug in negative urine samples. Each drug concentration was confirmed by LCMS/MS. All sample aliquots were blindly labeled by the person who prepared the samples and didn’t take part in the sample testing. For each concentration, tests were performed 1 replicate per run per lot (one operator per lot), 2 runs per day for 25 days in a randomized order. The results obtained for Tramadol 100, Propoxyphene 300, Fentanyl 1 and 6- monoacetylmorphine 10 are summarized in the following tables. The rest of the data for Amphetamine, Buprenorphine, Secobarbital, Benzodiazepines, Cocaine, EDDP, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, Nortriptyline and Marijuana were reported in k233019.

Tramadol (TRA) $\underline { { 1 0 0 ~ \mathrm { n g / m L } } }$   

<table><tr><td rowspan=2 colspan=1>Lot #</td><td rowspan=1 colspan=9>Concentration by LC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>-100%cutoff</td><td rowspan=1 colspan=1>-75%cutoff</td><td rowspan=1 colspan=1>-50%cutoff</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>+50%cutoff</td><td rowspan=1 colspan=1>+75%cutoff</td><td rowspan=1 colspan=1>+100%cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>49-/1+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td></tr></table>

Propoxyphene (PPX) 300 ng/mL   

<table><tr><td rowspan=2 colspan=1>Lot #</td><td rowspan=1 colspan=9>Concentration by LC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>-100%cutoff</td><td rowspan=1 colspan=1>-75%cutoff</td><td rowspan=1 colspan=1>-50%cutoff</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>+50%cutoff</td><td rowspan=1 colspan=1>+75%cutoff</td><td rowspan=1 colspan=1>+100%cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>49-/1+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>23-/27+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>1-/49+</td><td rowspan=1 colspan=1>0-50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td></tr></table>

Fentanyl (FYL) 1 ng/mL

<table><tr><td rowspan=2 colspan=1>Lot #</td><td rowspan=1 colspan=9>Concentration by LC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>-50%Cutoff</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>Cutoff+25%</td><td rowspan=1 colspan=1>Cutoff+50%</td><td rowspan=1 colspan=1>Cutoff+75%</td><td rowspan=1 colspan=1>Cutoff+100%</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>48-/2+</td><td rowspan=1 colspan=1>23-/27+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>49-/1+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td></tr></table>

6-monoacetylmorphine (6-MAM) 10 ng/mL   

<table><tr><td rowspan=2 colspan=1>Lot #</td><td rowspan=1 colspan=9>Concentration by LC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>-50%Cutoff</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>Cutoff+25%</td><td rowspan=1 colspan=1>Cutoff+50%</td><td rowspan=1 colspan=1>Cutoff+75%</td><td rowspan=1 colspan=1>Cutoff+100%</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>48-/2+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>1-/49+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>49-/1+</td><td rowspan=1 colspan=1>23-/27+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td><td rowspan=1 colspan=1>0-/50+</td></tr></table>

2. Linearity:

Not applicable.

3. Analytical Specificity/Interference:

# Cross-reactivity

To test the cross reactivity, target drugs, drug metabolites within the same class of drugs, or substances with similar molecular structures that potentially cross-react were spiked to drugfree specimens and these samples were tested by three different operators using three lots of Multi-Drug Rapid Test Cup. The cross-reacting substances with the lowest concentration that produced a positive result was identified and are listed in the table below. If no crossreactivity was observed the highest concentration tested is shown.

The study is reported only for Tramadol (TRA)100, Propoxyphene (PPX) 300, Fentanyl (FYL) 1 and 6-monoacetylmorphine (6-MAM)10. The data for Amphetamine, Buprenorphine, Secobarbital, Benzodiazepines, Cocaine, EDDP, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, Nortriptyline and Marijuana were reported in k233019.

<table><tr><td colspan="1" rowspan="1">TRA (Tramadol)Cutoff=100 ng/mL</td><td colspan="1" rowspan="1">Lowest concentration(ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Tramadol</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">N-Desmethyl-cis-tramadol</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">O-Desmethyl-cis-tramadol</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">Venlafaxine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">0.1%</td></tr><tr><td colspan="1" rowspan="1">(±)-O-Desmethylvenlafaxine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">0.1%</td></tr><tr><td colspan="1" rowspan="1">PPX (Propoxyphene)Cutoff=300 ng/mL</td><td colspan="1" rowspan="1">Lowest concentration(ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">(+)-Propoxyphene</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(+)-Norpropoxyphene</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">FYL (Fentanyl)Cut-off=1 ng/mL</td><td colspan="1" rowspan="1">Lowest concentration(ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Fentanyl</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Acetyl fentanyl</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Acrylfentanyl</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">ω-1-Hydroxyfentanyl</td><td colspan="1" rowspan="1">20000</td><td colspan="1" rowspan="1">0.005%</td></tr><tr><td colspan="1" rowspan="1">Isobutyryl fentanyl</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Ocfentanil</td><td colspan="1" rowspan="1">2.5</td><td colspan="1" rowspan="1">40%</td></tr><tr><td colspan="1" rowspan="1">Butyryl fentanyl</td><td colspan="1" rowspan="1">2.5</td><td colspan="1" rowspan="1">40%</td></tr><tr><td colspan="1" rowspan="1">Furanyl fentanyl</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">20%</td></tr><tr><td colspan="1" rowspan="1">Valeryl fentanyl</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">(±) β-hydroxythiofentanyl</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">4-Fluoro-isobutyrylfentanyl</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">2%</td></tr><tr><td colspan="1" rowspan="1">Para-fluorobutyryl fentanyl</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">25%</td></tr><tr><td colspan="1" rowspan="1">Para-fluoro fentanyl</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">33.3%</td></tr><tr><td colspan="1" rowspan="1">(±)-3-cis-methyl fentanyl</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">2%</td></tr><tr><td colspan="1" rowspan="1">Carfentanil</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">Sufentanil</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">Alfentanil</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">0.02%</td></tr><tr><td colspan="1" rowspan="1">Despropionyl fentanyl (4-ANPP)</td><td colspan="1" rowspan="1">2500</td><td colspan="1" rowspan="1">0.04%</td></tr><tr><td colspan="1" rowspan="1">Remifentanil</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Norfentanyl</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Acetyl norfentanyl</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Norcarfentanil</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">6-Acetyl morphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Amphetamine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Buprenorphineglucuronide</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">EDDP</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">EMDP</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Fluoxetine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Heroin</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Morphine-3-glucuronide</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Norbuprenorphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Norketamine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Normeperidine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Normorphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Noroxycodone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Pentazocine (Talwin)</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Pipamperone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Risperidone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Tapentadol</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Thioridazine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Tilidine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Tramadol</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Tramadol-O-Desmethyl</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Tramadol-N-Desmethyl</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Isotonitaze</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr><tr><td colspan="1" rowspan="1">Cyclopropylfentanyl</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">33.3%</td></tr><tr><td colspan="1" rowspan="1">AH-7921 HCL</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.001%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">6-MAM (6-monoacetylmorphine)Cutoff=10ng/mL</td><td colspan="1" rowspan="1">Lowest concentration(ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">6-Monoacetylmorphine</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Procaine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Thebaine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Diacetylmorphine (heroin)</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">3.3%</td></tr><tr><td colspan="1" rowspan="1">Acetylcodeine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Mitragynine (kratom)</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Norbuprenorphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">s-Monoacetylmorphine</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Ethylmorphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Levorphanol tartrate</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Morphine-3-β-D-glucuronide</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Normorphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Imipramine hydrochloride</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Levacetylmethadol (LAAM)</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">(±)-Methadone</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Naloxone hydrochloride</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Naltrexone hydrochloride</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Noroxycodone HCL</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Noroxymorphone HCL</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">(+)-Norpropoxyphene maleate</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone-3β-D-glucuronide</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Tapentadol HCl</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Tramadol hydrochloride</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Clobazam</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">D-Amphetamine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">(±)-Amphetamine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr></table>

# Interfering substances

Clinical urine samples may contain substances that could potentially interfere with the test. To evaluate interference, potential interfering substances found in human urine of physiological or pathological conditions were added to drug-free urine and target drugs urine with concentrations at $50 \%$ below and $50 \%$ above cut-off levels in the test. These urine samples were tested using three lots of Multi-Drug Rapid Test Cup and two configurations (combination of different cut off values) by six operators (three operator for each configuration). Compounds that showed no interference at a concentration of $1 0 0 ~ \mu \mathrm { g / m L }$ or at specified concentrations are summarized in the following table.

<table><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">D-Pseudoephedrine</td><td colspan="1" rowspan="1">Norfentanyl</td></tr><tr><td colspan="1" rowspan="1">Acetone (1000mg/dL)</td><td colspan="1" rowspan="1">Duloxetine</td><td colspan="1" rowspan="1">Noscapine</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">4-Dimethyl-aminoantipyrine</td><td colspan="1" rowspan="1">(+)-Naproxen</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic Acid</td><td colspan="1" rowspan="1">5, 5-Diphenylhydantoin</td><td colspan="1" rowspan="1">19-Norethindrone</td></tr><tr><td colspan="1" rowspan="1">Acyclovir</td><td colspan="1" rowspan="1">Ecgonine methyl ester</td><td colspan="1" rowspan="1">Octopamine</td></tr><tr><td colspan="1" rowspan="1">Albumin (100mg/dL)</td><td colspan="1" rowspan="1">EMDP</td><td colspan="1" rowspan="1">O-Hydroxyhippuric acid</td></tr><tr><td colspan="1" rowspan="1">Albuterol sulfate (Proair HFA)</td><td colspan="1" rowspan="1">Ephedrine</td><td colspan="1" rowspan="1">Olanzapine</td></tr><tr><td colspan="1" rowspan="1">Alpha Methadol</td><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Omeprazole</td></tr><tr><td colspan="1" rowspan="1">Aminophylline</td><td colspan="1" rowspan="1">Esomeprazole Magnesium (exceptMTD test)</td><td colspan="1" rowspan="1">Oxalic acid (100mg/dL)</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Estradiol</td><td colspan="1" rowspan="1">Oxolinic acid</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Estrone</td><td colspan="1" rowspan="1">Oxymetazoline</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">Ethanol (1%)</td><td colspan="1" rowspan="1">Paliperidone</td></tr><tr><td colspan="1" rowspan="1">Aripiprazole</td><td colspan="1" rowspan="1">Fenofibrate</td><td colspan="1" rowspan="1">Papaverine</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Penicillin-G</td></tr><tr><td colspan="1" rowspan="1">Aspirin</td><td colspan="1" rowspan="1">Fentanyl (except FYL test)</td><td colspan="1" rowspan="1">PenicillinV Potassium</td></tr><tr><td colspan="1" rowspan="1">Atomoxetine</td><td colspan="1" rowspan="1">Fluoxetine Hydrochloride</td><td colspan="1" rowspan="1">Perphenazine</td></tr><tr><td colspan="1" rowspan="1">Atorvastatin Calcium</td><td colspan="1" rowspan="1">Fluphenazine</td><td colspan="1" rowspan="1">Phenacetin</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">Fotemustine</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Azithromycin</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Phenethylamine</td></tr><tr><td colspan="1" rowspan="1">Baclofen</td><td colspan="1" rowspan="1">Gabapentin</td><td colspan="1" rowspan="1">Phenylethylamine</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">Galactose (10mg/dL)</td><td colspan="1" rowspan="1">Phenylpropanolamine</td></tr><tr><td colspan="1" rowspan="1">Benzocaine</td><td colspan="1" rowspan="1">Gamma Globulin (500mg/dL)</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Benzoic Acid</td><td colspan="1" rowspan="1">Gatifloxacin</td><td colspan="1" rowspan="1">Pregablin</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">Gemfibrozil</td><td colspan="1" rowspan="1">Procaine</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Promazine</td></tr><tr><td colspan="1" rowspan="1">Boric Acid (1%)</td><td colspan="1" rowspan="1">Glucose (3000mg/dL)</td><td colspan="1" rowspan="1">Promethazine</td></tr><tr><td colspan="1" rowspan="1">Bupropion</td><td colspan="1" rowspan="1">Guaiacol glyceryl ether</td><td colspan="1" rowspan="1">Propoxyphene (exceptPPX test)</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Propranolol</td></tr><tr><td colspan="1" rowspan="1">Cannabidiol</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Pseudoephedrine</td></tr><tr><td colspan="1" rowspan="1">Captopril</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">Pyridoxine</td></tr><tr><td colspan="1" rowspan="1">Carbamazepine</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">Pyrilamine</td></tr><tr><td colspan="1" rowspan="1">Carfentanil (except FYL test)</td><td colspan="1" rowspan="1">3-Hydroxytyramine</td><td colspan="1" rowspan="1">Pyrogallol</td></tr><tr><td colspan="1" rowspan="1">Carisoprodol</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Quetiapine</td></tr><tr><td colspan="1" rowspan="1">Cefradine</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Cephalexin</td><td colspan="1" rowspan="1">(+/-)-Isoproterenol</td><td colspan="1" rowspan="1">Quinolinic Acid</td></tr><tr><td colspan="1" rowspan="1">Chloralhydrate</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">R- (-)-Apomorphine</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">Ketoprofen</td><td colspan="1" rowspan="1">Ranitidine</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide (except BZOtest</td><td colspan="1" rowspan="1">LAAM HCI</td><td colspan="1" rowspan="1">Riboflavin (10mg/dL)</td></tr><tr><td colspan="1" rowspan="1">Chloroquine (except MET test)</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Rifampicin</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">L-Ascorbic Acid</td><td colspan="1" rowspan="1">Risperidone</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">L-Ephedrine</td><td colspan="1" rowspan="1">Salicylic Acid</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">L-Epinephrine</td><td colspan="1" rowspan="1">Serotonin (5-Hydroxytyramine)</td></tr><tr><td colspan="1" rowspan="1">Ciprofloxacin Hydrochloride</td><td colspan="1" rowspan="1">Levofloxacin Hydrochloride</td><td colspan="1" rowspan="1">Sertraline</td></tr><tr><td colspan="1" rowspan="1">Citalopram</td><td colspan="1" rowspan="1">Levonorgestrel</td><td colspan="1" rowspan="1">Sildenafil Citrate</td></tr><tr><td colspan="1" rowspan="1">Clarithromycin</td><td colspan="1" rowspan="1">Levothyroxine Sodium</td><td colspan="1" rowspan="1">Simvastatin</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">Lidocaine Hydrochloride</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Clozapine</td><td colspan="1" rowspan="1">Lisinopril</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Conjugated Estrogens</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Telmisartan</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Loratadine</td><td colspan="1" rowspan="1">Tetracycline</td></tr><tr><td colspan="1" rowspan="1">Creatine Hydrate</td><td colspan="1" rowspan="1">L-phenylephrine</td><td colspan="1" rowspan="1">Tetrahydrocortisone 3-(β- Dglucuronide)</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Magnesium</td><td colspan="1" rowspan="1">Tetrahydrocortisone, 3-acetate</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Cyclodextrin</td><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">Theophylline</td></tr><tr><td colspan="1" rowspan="1">(-)-Cotinine</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">(+)-Chlorpheniramine</td><td colspan="1" rowspan="1">Methapyrilene</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">D,L-Epinephrine</td><td colspan="1" rowspan="1">Methaqualone</td><td colspan="1" rowspan="1">Tramadol (except TRAtest)</td></tr><tr><td colspan="1" rowspan="1">D,L-Octopamine</td><td colspan="1" rowspan="1">Methoxyphenamine (exceptAMP/MET test)</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">d,1-Propranolol</td><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">Trifluoperazine</td></tr><tr><td colspan="1" rowspan="1">D,L-Tryptophan</td><td colspan="1" rowspan="1">Metoprolol Tartrate</td><td colspan="1" rowspan="1">Trimethobenzamide</td></tr><tr><td colspan="1" rowspan="1">D,L-Tyrosine</td><td colspan="1" rowspan="1">Metronidazole (300ug/ml)</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">Delorazepam (except BZOtest)</td><td colspan="1" rowspan="1">Mifepristone</td><td colspan="1" rowspan="1">Tryptamine</td></tr><tr><td colspan="1" rowspan="1">Deoxycorticosterone</td><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1">Desloratadine</td><td colspan="1" rowspan="1">NaCl (4000mg/dL)</td><td colspan="1" rowspan="1">Urea (2000mg/dL)</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Nalidixic Acid</td><td colspan="1" rowspan="1">Uric Acid</td></tr><tr><td colspan="1" rowspan="1">Diclofenac</td><td colspan="1" rowspan="1">Naloxone hydrochloride (exceptOXY test)</td><td colspan="1" rowspan="1">Valproic acid(250ug/ml)</td></tr><tr><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">Venlafaxine HCl (exceptTRA test)</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine HCl</td><td colspan="1" rowspan="1">Nicotine</td><td colspan="1" rowspan="1">Vitamin B2</td></tr><tr><td colspan="1" rowspan="1">Disopyramide (except MTDtest)</td><td colspan="1" rowspan="1">Nicotinic Acid</td><td colspan="1" rowspan="1">Vitamin C</td></tr><tr><td colspan="1" rowspan="1">Dopamine HC1</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Zaleplon</td></tr><tr><td colspan="1" rowspan="1">Doxepin</td><td colspan="1" rowspan="1">Nitroglycerin</td><td colspan="1" rowspan="1">Zomepirac sodium salt</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">Nordoxepin</td><td colspan="1" rowspan="1"></td></tr></table>

# Effect of Urine Specific Gravity and Urine pH

The effect of $\mathsf { p H }$ and specific gravity on the accuracy of test measurement of the Multi-Drug Rapid Test Cup were evaluated using pooled urine specimens with concentrations of 0 (drugfree), at $50 \%$ below and $50 \%$ above each corresponding cutoff. The results demonstrated that $\mathsf { p H }$ levels of 4 to 9 and specific gravity levels of 1.000 to 1.035 do not affect the results of the assays.

4. Assay Reportable Range: Not applicable.

5. Traceability, Stability, Expected Values (Controls, Calibrators, or Methods):

All drug calibrators of the device are traceable to available commercial reference materials.

6. Detection Limit:

See precision data in Section VII.A.1., above, for assay performance around the claimed cutoff concentrations.

# 7. Assay Cut-Off:

Characterization of how the device performs analytically around the claimed cutoff concentration appears in the precision section VII.A.1., above.

# B Comparison Studies:

# 1. Method Comparison with Predicate Device:

Eighty (40 negative and 40 positive) unaltered clinical urine samples for each drug were analyzed by LC/MS and by three lots of Multi-Drug Rapid Test Cup device. Samples concentrations are confirmed by LC/MS, ranging from drug-free, $< - 5 0 \%$ Cutoff, $- 5 0 \%$ Cutoff $\sim$ Cutoff, Cutoff $\sim + 5 0 \%$ Cutoff, $5+ 5 0 \%$ Cutoff. The study was conducted by 3 operators (one operator per lot) at an in-house laboratory. Method comparison data were reported only for Tramadol (TRA)100, Propoxyphene (PPX) 300, Fentanyl (FYL) 1 and 6- monoacetylmorphine (6-MAM)10. The data for Amphetamine, Buprenorphine, Secobarbital, Benzodiazepines, Cocaine, EDDP, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, Nortriptyline and Marijuana were reported in k233019.

<table><tr><td colspan="1" rowspan="1">Drug</td><td colspan="2" rowspan="1">Test Cup Result</td><td colspan="1" rowspan="1">Drug-Free</td><td colspan="1" rowspan="1">LowNegativebyLC-MS/MS(less than -50%)</td><td colspan="1" rowspan="1">NearCutoffNegativeby LC-MS/MS(Between -50% andthe Cutoff)</td><td colspan="1" rowspan="1">NearCutoffPositive byLC-MS/MS(Betweenthe cutoffand +50%)</td><td colspan="1" rowspan="1">HighPositive byLC-MS/MS(greaterthan+50%)</td></tr><tr><td colspan="1" rowspan="6">TRA</td><td colspan="1" rowspan="2">OperatorA</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">29</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">OperatorB</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">29</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">OperatorC</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">29</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="6">PPX</td><td colspan="1" rowspan="2">OperatorA</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">30</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">OperatorB</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">30</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">OperatorC</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">30</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="6">6-MAM</td><td colspan="1" rowspan="2">OperatorA</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">26</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">OperatorB</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">26</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">OperatorC</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">26</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="6">FYL</td><td colspan="1" rowspan="2">OperatorA</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">16</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">OperatorB</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">16</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">OperatorC</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">16</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td></tr></table>

Discordant Results are summarized below.   

<table><tr><td rowspan=1 colspan=1>Drug</td><td rowspan=1 colspan=1>Operator</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS/MSResult (ng/mL)</td><td rowspan=1 colspan=1>Test Result</td></tr><tr><td rowspan=2 colspan=1>TRA 100</td><td rowspan=1 colspan=1>A, C</td><td rowspan=1 colspan=1>S2148</td><td rowspan=1 colspan=1>91.6</td><td rowspan=1 colspan=1>+</td></tr><tr><td rowspan=1 colspan=1>B, C</td><td rowspan=1 colspan=1>S2157</td><td rowspan=1 colspan=1>103.0</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=3 colspan=1>PPX 300</td><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>S2052</td><td rowspan=1 colspan=1>286.3</td><td rowspan=1 colspan=1>+</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>S2017</td><td rowspan=1 colspan=1>280.6</td><td rowspan=1 colspan=1>+</td></tr><tr><td rowspan=1 colspan=1>C</td><td rowspan=1 colspan=1>S2018</td><td rowspan=1 colspan=1>319.8</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=3 colspan=1>6-MAM 10</td><td rowspan=1 colspan=1>A, C</td><td rowspan=1 colspan=1>S2249</td><td rowspan=1 colspan=1>9.5</td><td rowspan=1 colspan=1>+</td></tr><tr><td rowspan=1 colspan=1>B,C</td><td rowspan=1 colspan=1>S2236</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>+</td></tr><tr><td rowspan=1 colspan=1>B, C</td><td rowspan=1 colspan=1>S2228</td><td rowspan=1 colspan=1>10.2</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=9 colspan=1>FYL 1</td><td rowspan=1 colspan=1>A, C</td><td rowspan=1 colspan=1>S1425</td><td rowspan=1 colspan=1>1.02</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>S1420</td><td rowspan=1 colspan=1>0.87</td><td rowspan=1 colspan=1>+</td></tr><tr><td rowspan=1 colspan=1>A, B</td><td rowspan=1 colspan=1>S1447</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>A, B</td><td rowspan=1 colspan=1>S1442</td><td rowspan=1 colspan=1>0.91</td><td rowspan=1 colspan=1>+</td></tr><tr><td rowspan=1 colspan=1>B, C</td><td rowspan=1 colspan=1>S1402</td><td rowspan=1 colspan=1>0.92</td><td rowspan=1 colspan=1>+</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>S1422</td><td rowspan=1 colspan=1>1.08</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>S1465</td><td rowspan=1 colspan=1>0.92</td><td rowspan=1 colspan=1>+</td></tr><tr><td rowspan=1 colspan=1>C</td><td rowspan=1 colspan=1>S1453</td><td rowspan=1 colspan=1>0.82</td><td rowspan=1 colspan=1>+</td></tr><tr><td rowspan=1 colspan=1>C</td><td rowspan=1 colspan=1>S1439</td><td rowspan=1 colspan=1>1.02</td><td rowspan=1 colspan=1>-</td></tr></table>

# Lay User Study

A lay user study was conducted to evaluate its two configurations of the 18 drugs for the Multi-Drug Rapid Test Cup. Configuration 1 included COC 300, OPI/MOP 2000, AMP 1000 and MET 1000, AND configuration 2 included COC 150, MOP 300, AMP 500 and MET 500. The study was performed at three intended user sites by 280 lay users (140 for each configuration), and each lay user tested only one sample. The lay users had diverse educational and professional backgrounds and ranged in age from 20 to $> 5 0$ years. Urine samples were prepared at the following concentrations: $- 1 0 0 \%$ , $+ / - 7 5 \%$ , $+ / - 5 0 \%$ , $+ / - 2 5 \%$ of the cutoff by spiking drugs into drug free-pooled urine specimens. The concentrations of the samples were confirmed by LC-MS/MS. Each sample was aliquoted into individual

containers and blind-labeled. Each participant was provided with the package insert, 1 blind labeled sample and a device. Results are shown below.

<table><tr><td colspan="10" rowspan="1">Results for configuration I</td></tr><tr><td colspan="1" rowspan="2">Drug</td><td colspan="1" rowspan="2">Cutoff(ng/mL)</td><td colspan="1" rowspan="2">Results</td><td colspan="7" rowspan="1">Concentration</td></tr><tr><td colspan="1" rowspan="1">-100%cutoff</td><td colspan="1" rowspan="1">-75%cutoff</td><td colspan="1" rowspan="1">-50%cutoff</td><td colspan="1" rowspan="1">-25%cutoff</td><td colspan="1" rowspan="1">+25%cutoff</td><td colspan="1" rowspan="1">+50%cutoff</td><td colspan="1" rowspan="1">+75%cutoff</td></tr><tr><td colspan="1" rowspan="4">AMP</td><td colspan="1" rowspan="4">1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">BAR</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">BZO</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">BUP</td><td colspan="1" rowspan="4">10</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">COC</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">EDDP</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MDMA</td><td colspan="1" rowspan="4">500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MET</td><td colspan="1" rowspan="4">1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">MOP</td><td colspan="1" rowspan="2">2000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="2"></td><td colspan="1" rowspan="2"></td><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MTD</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">OXY</td><td colspan="1" rowspan="4">100</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">PCP</td><td colspan="1" rowspan="4">25</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">TCA</td><td colspan="1" rowspan="4">1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">THC</td><td colspan="1" rowspan="4">50</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">TRA</td><td colspan="1" rowspan="4">100</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">PPX</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">FYL</td><td colspan="1" rowspan="4">1</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">85.0%</td><td colspan="1" rowspan="1">100.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">6-MAM</td><td colspan="1" rowspan="4">10</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr></table>

# Results for configuration 2

<table><tr><td colspan="1" rowspan="2">Drug</td><td colspan="1" rowspan="2">Cutoff(ng/mL)</td><td colspan="1" rowspan="2">Results</td><td colspan="7" rowspan="1">Concentration</td></tr><tr><td colspan="1" rowspan="1">-100%cutoff</td><td colspan="1" rowspan="1">-75%cutoff</td><td colspan="1" rowspan="1">-50%cutoff</td><td colspan="1" rowspan="1">-25%cutoff</td><td colspan="1" rowspan="1">+25%cutoff</td><td colspan="1" rowspan="1">+50%cutoff</td><td colspan="1" rowspan="1">+75%cutoff</td></tr><tr><td colspan="1" rowspan="4">AMP</td><td colspan="1" rowspan="4">500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">BAR</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">BZO</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">BUP</td><td colspan="1" rowspan="4">10</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">COC</td><td colspan="1" rowspan="4">150</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">EDDP</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MDMA</td><td colspan="1" rowspan="4">500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MET</td><td colspan="1" rowspan="4">500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MOP</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="3">MTD</td><td colspan="1" rowspan="3">300</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">OXY</td><td colspan="1" rowspan="4">100</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">PCP</td><td colspan="1" rowspan="4">25</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">TCA</td><td colspan="1" rowspan="4">1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">THC</td><td colspan="1" rowspan="4">50</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">TRA</td><td colspan="1" rowspan="4">100</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">PPX</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">95.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">FYL</td><td colspan="1" rowspan="4">1</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">100.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">6-MAM</td><td colspan="1" rowspan="4">10</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">90.0%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr></table>

Lay users were also given surveys on the ease of understanding the package insert instructions. All lay users indicated that the device instructions can be easily followed. A Flesch-Kincaid reading analysis was performed on each package insert and the scores revealed a reading Grade Level of 7.

2. Matrix Comparison: Not applicable.

# C Clinical Studies:

1. Clinical Sensitivity: Not applicable.

2. Clinical Specificity: Not applicable.

3. Other Clinical Supportive Data (When 1. and 2. Are Not Applicable): Not applicable.

# D Clinical Cut-Off:

Not applicable. E Expected Values/Reference Range: Not applicable

# VIII Proposed Labeling:

The labeling supports the finding of substantial equivalence for this device.

# IX Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.